DMD and Duchenne muscular dystrophy: Due to these unfavorable side effects found in the historical development of DMD gene therapies, cell-based therapies of myoblast origin have been tested as an alternative option for DMD (Gussoni et al. 1997; Skuk and Tremblay 2015, 2016).